TrialDiabetic medicine : a journal of the British Diabetic Association2008

Beneficial effects of once-daily liraglutide, a human glucagon-like peptide-1 analogue, on cardiovascular risk biomarkers in patients with Type 2 diabetes.

J-P Courrèges et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.